Format

Send to

Choose Destination
Exp Cell Res. 2012 May 15;318(9):1057-67. doi: 10.1016/j.yexcr.2012.02.026. Epub 2012 Mar 3.

Renal cancer: oxygen meets metabolism.

Author information

1
Department of Medicine, Vanderbilt School of Medicine, Nashville, TN 37232, USA. volker.haase@vanderbilt.edu

Abstract

Over the last two decades molecular studies of inherited tumor syndromes that are associated with the development of kidney cancer have led to the identification of genes and biochemical pathways, which play key roles in the malignant transformation of renal epithelial cells. Some of these findings have broad biological impact and extend beyond renal cancer. This review's focus is on the von Hippel-Lindau (VHL)/hypoxia-inducible factor (HIF) oxygen-sensing pathway and its role in physiology, energy metabolism and tumorigenesis.

PMID:
22406000
PMCID:
PMC3334413
DOI:
10.1016/j.yexcr.2012.02.026
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center